Report Cover

Global and United States Small Molecule Active Pharmaceutical Ingredient Market Report & Forecast 2022-2028


Small Molecule Active Pharmaceutical Ingredient market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Small Molecule Active Pharmaceutical Ingredient market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Small Molecule Active Pharmaceutical Ingredient market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
    Standard API
    High Potency API
Segment by Application
    Cardiovascular Diseases
    Respiratory Disorders
    Infectious Diseases
    Others
By Region
    North America
        U.S.
        Canada
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Asia-Pacific
        China
        Japan
        South Korea
        India
        Australia
        Taiwan
        Indonesia
        Thailand
        Malaysia
        Philippines
        Vietnam
    Latin America
        Mexico
        Brazil
        Argentina
    Middle East & Africa
        Turkey
        Saudi Arabia
        U.A.E
By Company
    Johnson Matthey
    Siegfried Holding AG
    Pfizer
    Sanofi S.A.
    Novartis AG,
    Bristol-Myers Squibb
    Boehringer Ingelheim GmbH
    GlaxoSmithKline
    Albany Molecular Research Inc.
    Bachem Holding AG
    PCAS
    Patheon N.V.
    AstraZeneca
    Johnson & Johnson
    Merck & Co
    BASF SE
    Catalent Inc.
    Teva Pharmaceuticals
    Roche
    Cambrex Corporation
    GILEAD Science Inc.
1 Study Coverage
    1.1 Small Molecule Active Pharmaceutical Ingredient Product Introduction
    1.2 Global Small Molecule Active Pharmaceutical Ingredient Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Small Molecule Active Pharmaceutical Ingredient Sales in US$ Million for the Year 2017-2028
        1.2.2 Global Small Molecule Active Pharmaceutical Ingredient Sales in Volume for the Year 2017-2028
    1.3 United States Small Molecule Active Pharmaceutical Ingredient Outlook 2017 VS 2022 VS 2028
        1.3.1 United States Small Molecule Active Pharmaceutical Ingredient Sales in US$ Million for the Year 2017-2028
        1.3.2 United States Small Molecule Active Pharmaceutical Ingredient Sales in Volume for the Year 2017-2028
    1.4 Small Molecule Active Pharmaceutical Ingredient Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.4.1 The Market Share of United States Small Molecule Active Pharmaceutical Ingredient in Global, 2017 VS 2022 VS 2028
        1.4.2 The Growth Rate of Small Molecule Active Pharmaceutical Ingredient Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.5 Small Molecule Active Pharmaceutical Ingredient Market Dynamics
        1.5.1 Small Molecule Active Pharmaceutical Ingredient Industry Trends
        1.5.2 Small Molecule Active Pharmaceutical Ingredient Market Drivers
        1.5.3 Small Molecule Active Pharmaceutical Ingredient Market Challenges
        1.5.4 Small Molecule Active Pharmaceutical Ingredient Market Restraints
    1.6 Study Objectives
    1.7 Years Considered
2 Market by Type
    2.1 Small Molecule Active Pharmaceutical Ingredient Market Segment by Type
        2.1.1 Standard API
        2.1.2 High Potency API
    2.2 Global Small Molecule Active Pharmaceutical Ingredient Market Size by Type
        2.2.1 Global Small Molecule Active Pharmaceutical Ingredient Sales in Value, by Type (2017, 2022 & 2028)
        2.2.2 Global Small Molecule Active Pharmaceutical Ingredient Sales in Volume, by Type (2017, 2022 & 2028)
        2.2.3 Global Small Molecule Active Pharmaceutical Ingredient Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    2.3 United States Small Molecule Active Pharmaceutical Ingredient Market Size by Type
        2.3.1 United States Small Molecule Active Pharmaceutical Ingredient Sales in Value, by Type (2017, 2022 & 2028)
        2.3.2 United States Small Molecule Active Pharmaceutical Ingredient Sales in Volume, by Type (2017, 2022 & 2028)
        2.3.3 United States Small Molecule Active Pharmaceutical Ingredient Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
    3.1 Small Molecule Active Pharmaceutical Ingredient Market Segment by Application
        3.1.1 Cardiovascular Diseases
        3.1.2 Respiratory Disorders
        3.1.3 Infectious Diseases
        3.1.4 Others
    3.2 Global Small Molecule Active Pharmaceutical Ingredient Market Size by Application
        3.2.1 Global Small Molecule Active Pharmaceutical Ingredient Sales in Value, by Application (2017, 2022 & 2028)
        3.2.2 Global Small Molecule Active Pharmaceutical Ingredient Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 Global Small Molecule Active Pharmaceutical Ingredient Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    3.3 United States Small Molecule Active Pharmaceutical Ingredient Market Size by Application
        3.3.1 United States Small Molecule Active Pharmaceutical Ingredient Sales in Value, by Application (2017, 2022 & 2028)
        3.3.2 United States Small Molecule Active Pharmaceutical Ingredient Sales in Volume, by Application (2017, 2022 & 2028)
        3.3.3 United States Small Molecule Active Pharmaceutical Ingredient Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Small Molecule Active Pharmaceutical Ingredient Competitor Landscape by Company
    4.1 Global Small Molecule Active Pharmaceutical Ingredient Market Size by Company
        4.1.1 Top Global Small Molecule Active Pharmaceutical Ingredient Manufacturers Ranked by Revenue (2021)
        4.1.2 Global Small Molecule Active Pharmaceutical Ingredient Revenue by Manufacturer (2017-2022)
        4.1.3 Global Small Molecule Active Pharmaceutical Ingredient Sales by Manufacturer (2017-2022)
        4.1.4 Global Small Molecule Active Pharmaceutical Ingredient Price by Manufacturer (2017-2022)
    4.2 Global Small Molecule Active Pharmaceutical Ingredient Concentration Ratio (CR)
        4.2.1 Small Molecule Active Pharmaceutical Ingredient Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Small Molecule Active Pharmaceutical Ingredient in 2021
        4.2.3 Global Small Molecule Active Pharmaceutical Ingredient Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Small Molecule Active Pharmaceutical Ingredient Manufacturing Base Distribution, Product Type
        4.3.1 Global Small Molecule Active Pharmaceutical Ingredient Manufacturers, Headquarters and Distribution of Producing Region
        4.3.2 Manufacturers Small Molecule Active Pharmaceutical Ingredient Product Type
        4.3.3 Date of International Manufacturers Enter into Small Molecule Active Pharmaceutical Ingredient Market
    4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    4.5 United States Small Molecule Active Pharmaceutical Ingredient Market Size by Company
        4.5.1 Top Small Molecule Active Pharmaceutical Ingredient Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Small Molecule Active Pharmaceutical Ingredient Revenue by Players (2020, 2021 & 2022)
        4.5.3 United States Small Molecule Active Pharmaceutical Ingredient Sales by Players (2020, 2021 & 2022)
5 Global Small Molecule Active Pharmaceutical Ingredient Market Size by Region
    5.1 Global Small Molecule Active Pharmaceutical Ingredient Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Small Molecule Active Pharmaceutical Ingredient Market Size in Volume by Region (2017-2028)
        5.2.1 Global Small Molecule Active Pharmaceutical Ingredient Sales in Volume by Region: 2017-2022
        5.2.2 Global Small Molecule Active Pharmaceutical Ingredient Sales in Volume Forecast by Region (2023-2028)
    5.3 Global Small Molecule Active Pharmaceutical Ingredient Market Size in Value by Region (2017-2028)
        5.3.1 Global Small Molecule Active Pharmaceutical Ingredient Sales in Value by Region: 2017-2022
        5.3.2 Global Small Molecule Active Pharmaceutical Ingredient Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Small Molecule Active Pharmaceutical Ingredient Market Size YoY Growth 2017-2028
        6.1.2 North America Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Small Molecule Active Pharmaceutical Ingredient Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Small Molecule Active Pharmaceutical Ingredient Market Size YoY Growth 2017-2028
        6.3.2 Europe Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Small Molecule Active Pharmaceutical Ingredient Market Size YoY Growth 2017-2028
        6.4.2 Latin America Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Johnson Matthey
        7.1.1 Johnson Matthey Corporation Information
        7.1.2 Johnson Matthey Description and Business Overview
        7.1.3 Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2017-2022)
        7.1.4 Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Products Offered
        7.1.5 Johnson Matthey Recent Development
    7.2 Siegfried Holding AG
        7.2.1 Siegfried Holding AG Corporation Information
        7.2.2 Siegfried Holding AG Description and Business Overview
        7.2.3 Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2017-2022)
        7.2.4 Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Products Offered
        7.2.5 Siegfried Holding AG Recent Development
    7.3 Pfizer
        7.3.1 Pfizer Corporation Information
        7.3.2 Pfizer Description and Business Overview
        7.3.3 Pfizer Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2017-2022)
        7.3.4 Pfizer Small Molecule Active Pharmaceutical Ingredient Products Offered
        7.3.5 Pfizer Recent Development
    7.4 Sanofi S.A.
        7.4.1 Sanofi S.A. Corporation Information
        7.4.2 Sanofi S.A. Description and Business Overview
        7.4.3 Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2017-2022)
        7.4.4 Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Products Offered
        7.4.5 Sanofi S.A. Recent Development
    7.5 Novartis AG,
        7.5.1 Novartis AG, Corporation Information
        7.5.2 Novartis AG, Description and Business Overview
        7.5.3 Novartis AG, Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2017-2022)
        7.5.4 Novartis AG, Small Molecule Active Pharmaceutical Ingredient Products Offered
        7.5.5 Novartis AG, Recent Development
    7.6 Bristol-Myers Squibb
        7.6.1 Bristol-Myers Squibb Corporation Information
        7.6.2 Bristol-Myers Squibb Description and Business Overview
        7.6.3 Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2017-2022)
        7.6.4 Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Products Offered
        7.6.5 Bristol-Myers Squibb Recent Development
    7.7 Boehringer Ingelheim GmbH
        7.7.1 Boehringer Ingelheim GmbH Corporation Information
        7.7.2 Boehringer Ingelheim GmbH Description and Business Overview
        7.7.3 Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2017-2022)
        7.7.4 Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Products Offered
        7.7.5 Boehringer Ingelheim GmbH Recent Development
    7.8 GlaxoSmithKline
        7.8.1 GlaxoSmithKline Corporation Information
        7.8.2 GlaxoSmithKline Description and Business Overview
        7.8.3 GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2017-2022)
        7.8.4 GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Products Offered
        7.8.5 GlaxoSmithKline Recent Development
    7.9 Albany Molecular Research Inc.
        7.9.1 Albany Molecular Research Inc. Corporation Information
        7.9.2 Albany Molecular Research Inc. Description and Business Overview
        7.9.3 Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2017-2022)
        7.9.4 Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Products Offered
        7.9.5 Albany Molecular Research Inc. Recent Development
    7.10 Bachem Holding AG
        7.10.1 Bachem Holding AG Corporation Information
        7.10.2 Bachem Holding AG Description and Business Overview
        7.10.3 Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2017-2022)
        7.10.4 Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Products Offered
        7.10.5 Bachem Holding AG Recent Development
    7.11 PCAS
        7.11.1 PCAS Corporation Information
        7.11.2 PCAS Description and Business Overview
        7.11.3 PCAS Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2017-2022)
        7.11.4 PCAS Small Molecule Active Pharmaceutical Ingredient Products Offered
        7.11.5 PCAS Recent Development
    7.12 Patheon N.V.
        7.12.1 Patheon N.V. Corporation Information
        7.12.2 Patheon N.V. Description and Business Overview
        7.12.3 Patheon N.V. Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2017-2022)
        7.12.4 Patheon N.V. Products Offered
        7.12.5 Patheon N.V. Recent Development
    7.13 AstraZeneca
        7.13.1 AstraZeneca Corporation Information
        7.13.2 AstraZeneca Description and Business Overview
        7.13.3 AstraZeneca Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2017-2022)
        7.13.4 AstraZeneca Products Offered
        7.13.5 AstraZeneca Recent Development
    7.14 Johnson & Johnson
        7.14.1 Johnson & Johnson Corporation Information
        7.14.2 Johnson & Johnson Description and Business Overview
        7.14.3 Johnson & Johnson Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2017-2022)
        7.14.4 Johnson & Johnson Products Offered
        7.14.5 Johnson & Johnson Recent Development
    7.15 Merck & Co
        7.15.1 Merck & Co Corporation Information
        7.15.2 Merck & Co Description and Business Overview
        7.15.3 Merck & Co Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2017-2022)
        7.15.4 Merck & Co Products Offered
        7.15.5 Merck & Co Recent Development
    7.16 BASF SE
        7.16.1 BASF SE Corporation Information
        7.16.2 BASF SE Description and Business Overview
        7.16.3 BASF SE Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2017-2022)
        7.16.4 BASF SE Products Offered
        7.16.5 BASF SE Recent Development
    7.17 Catalent Inc.
        7.17.1 Catalent Inc. Corporation Information
        7.17.2 Catalent Inc. Description and Business Overview
        7.17.3 Catalent Inc. Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2017-2022)
        7.17.4 Catalent Inc. Products Offered
        7.17.5 Catalent Inc. Recent Development
    7.18 Teva Pharmaceuticals
        7.18.1 Teva Pharmaceuticals Corporation Information
        7.18.2 Teva Pharmaceuticals Description and Business Overview
        7.18.3 Teva Pharmaceuticals Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2017-2022)
        7.18.4 Teva Pharmaceuticals Products Offered
        7.18.5 Teva Pharmaceuticals Recent Development
    7.19 Roche
        7.19.1 Roche Corporation Information
        7.19.2 Roche Description and Business Overview
        7.19.3 Roche Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2017-2022)
        7.19.4 Roche Products Offered
        7.19.5 Roche Recent Development
    7.20 Cambrex Corporation
        7.20.1 Cambrex Corporation Corporation Information
        7.20.2 Cambrex Corporation Description and Business Overview
        7.20.3 Cambrex Corporation Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2017-2022)
        7.20.4 Cambrex Corporation Products Offered
        7.20.5 Cambrex Corporation Recent Development
    7.21 GILEAD Science Inc.
        7.21.1 GILEAD Science Inc. Corporation Information
        7.21.2 GILEAD Science Inc. Description and Business Overview
        7.21.3 GILEAD Science Inc. Small Molecule Active Pharmaceutical Ingredient Sales, Revenue and Gross Margin (2017-2022)
        7.21.4 GILEAD Science Inc. Products Offered
        7.21.5 GILEAD Science Inc. Recent Development
8 Industry Chain and Sales Channels Analysis
    8.1 Small Molecule Active Pharmaceutical Ingredient Industry Chain Analysis
    8.2 Small Molecule Active Pharmaceutical Ingredient Key Raw Materials
        8.2.1 Key Raw Materials
        8.2.2 Small Molecule Active Pharmaceutical Ingredient Distributors
    8.3 Small Molecule Active Pharmaceutical Ingredient Production Mode & Process
    8.4 Small Molecule Active Pharmaceutical Ingredient Sales and Marketing
        8.4.1 Small Molecule Active Pharmaceutical Ingredient Sales Channels
        8.4.2 Small Molecule Active Pharmaceutical Ingredient Distributors
    8.5 Small Molecule Active Pharmaceutical Ingredient Customers
9 Research Findings and Conclusion
10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

List of Tables Table 1. Small Molecule Active Pharmaceutical Ingredient CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028 Table 2. Small Molecule Active Pharmaceutical Ingredient Market Trends Table 3. Small Molecule Active Pharmaceutical Ingredient Market Drivers Table 4. Small Molecule Active Pharmaceutical Ingredient Market Challenges Table 5. Small Molecule Active Pharmaceutical Ingredient Market Restraints Table 6. Global Small Molecule Active Pharmaceutical Ingredient Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 7. United States Small Molecule Active Pharmaceutical Ingredient Sales by Type: 2017 VS 2022 VS 2028 (US$ Million) Table 8. Global Small Molecule Active Pharmaceutical Ingredient Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 9. United States Small Molecule Active Pharmaceutical Ingredient Sales by Application: 2017 VS 2022 VS 2028 (US$ Million) Table 10. Top Small Molecule Active Pharmaceutical Ingredient Manufacturers in Global Market, Ranking by Revenue (2021) Table 11. Global Small Molecule Active Pharmaceutical Ingredient Revenue by Manufacturer, (US$ Million), 2017-2022 Table 12. Global Small Molecule Active Pharmaceutical Ingredient Revenue Share by Manufacturer, 2017-2022 Table 13. Global Small Molecule Active Pharmaceutical Ingredient Sales by Manufacturer, (MT), 2017-2022 Table 14. Global Small Molecule Active Pharmaceutical Ingredient Sales Share by Manufacturer, 2017-2022 Table 15. Global Small Molecule Active Pharmaceutical Ingredient Price by Manufacturer (2017-2022) & (USD/MT) Table 16. Global Small Molecule Active Pharmaceutical Ingredient Manufacturers Market Concentration Ratio (CR5 and HHI) Table 17. Global Small Molecule Active Pharmaceutical Ingredient by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Active Pharmaceutical Ingredient as of 2021) Table 18. Top Players of Small Molecule Active Pharmaceutical Ingredient in Global Market, Headquarters and Distribution of Producing Region Table 19. Manufacturers Small Molecule Active Pharmaceutical Ingredient Product Type Table 20. Date of International Manufacturers Enter into Small Molecule Active Pharmaceutical Ingredient Market Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans Table 22. Top Small Molecule Active Pharmaceutical Ingredient Players in United States Market, Ranking by Revenue (2021) Table 23. United States Small Molecule Active Pharmaceutical Ingredient Revenue by Players, (US$ Million), 2020, 2021 & 2022 Table 24. United States Small Molecule Active Pharmaceutical Ingredient Revenue Share by Players, 2020, 2021 & 2022 Table 25. United States Small Molecule Active Pharmaceutical Ingredient Sales by Players, (MT), 2020, 2021 & 2022 Table 26. United States Small Molecule Active Pharmaceutical Ingredient Sales Share by Players, 2020, 2021 & 2022 Table 27. Global Small Molecule Active Pharmaceutical Ingredient Market Size by Region (US$ Million): 2017 VS 2022 VS 2028 Table 28. Global Small Molecule Active Pharmaceutical Ingredient Sales in Volume by Region (2017-2022) & (MT) Table 29. Global Small Molecule Active Pharmaceutical Ingredient Sales in Volume Forecast by Region (2023-2028) & (MT) Table 30. Global Small Molecule Active Pharmaceutical Ingredient Sales in Value by Region (2017-2022) & (US$ Million) Table 31. Global Small Molecule Active Pharmaceutical Ingredient Sales in Value Forecast by Region (2023-2028) & (US$ Million) Table 32. North America Small Molecule Active Pharmaceutical Ingredient Sales in Volume by Country (2017-2028) & (MT) Table 33. North America Small Molecule Active Pharmaceutical Ingredient Sales in Value by Country (2017-2028) & (US$ Million) Table 34. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Sales in Volume by Region (2017-2028) & (MT) Table 35. Asia Pacific Small Molecule Active Pharmaceutical Ingredient Sales in Value by Region (2017-2028) & (US$ Million) Table 36. Europe Small Molecule Active Pharmaceutical Ingredient Sales in Volume by Country (2017-2028) & (MT) Table 37. Europe Small Molecule Active Pharmaceutical Ingredient Sales in Value by Country (2017-2028) & (US$ Million) Table 38. Latin America Small Molecule Active Pharmaceutical Ingredient Sales in Volume by Country (2017-2028) & (MT) Table 39. Latin Americaa Small Molecule Active Pharmaceutical Ingredient Sales in Value by Country (2017-2028) & (US$ Million) Table 40. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales in Volume by Country (2017-2028) & (MT) Table 41. Middle East and Africa Small Molecule Active Pharmaceutical Ingredient Sales in Value by Country (2017-2028) & (US$ Million) Table 42. Johnson Matthey Corporation Information Table 43. Johnson Matthey Description and Business Overview Table 44. Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 45. Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Product Table 46. Johnson Matthey Recent Development Table 47. Siegfried Holding AG Corporation Information Table 48. Siegfried Holding AG Description and Business Overview Table 49. Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 50. Siegfried Holding AG Product Table 51. Siegfried Holding AG Recent Development Table 52. Pfizer Corporation Information Table 53. Pfizer Description and Business Overview Table 54. Pfizer Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 55. Pfizer Product Table 56. Pfizer Recent Development Table 57. Sanofi S.A. Corporation Information Table 58. Sanofi S.A. Description and Business Overview Table 59. Sanofi S.A. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 60. Sanofi S.A. Product Table 61. Sanofi S.A. Recent Development Table 62. Novartis AG, Corporation Information Table 63. Novartis AG, Description and Business Overview Table 64. Novartis AG, Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 65. Novartis AG, Product Table 66. Novartis AG, Recent Development Table 67. Bristol-Myers Squibb Corporation Information Table 68. Bristol-Myers Squibb Description and Business Overview Table 69. Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 70. Bristol-Myers Squibb Product Table 71. Bristol-Myers Squibb Recent Development Table 72. Boehringer Ingelheim GmbH Corporation Information Table 73. Boehringer Ingelheim GmbH Description and Business Overview Table 74. Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 75. Boehringer Ingelheim GmbH Product Table 76. Boehringer Ingelheim GmbH Recent Development Table 77. GlaxoSmithKline Corporation Information Table 78. GlaxoSmithKline Description and Business Overview Table 79. GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 80. GlaxoSmithKline Product Table 81. GlaxoSmithKline Recent Development Table 82. Albany Molecular Research Inc. Corporation Information Table 83. Albany Molecular Research Inc. Description and Business Overview Table 84. Albany Molecular Research Inc. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 85. Albany Molecular Research Inc. Product Table 86. Albany Molecular Research Inc. Recent Development Table 87. Bachem Holding AG Corporation Information Table 88. Bachem Holding AG Description and Business Overview Table 89. Bachem Holding AG Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 90. Bachem Holding AG Product Table 91. Bachem Holding AG Recent Development Table 92. PCAS Corporation Information Table 93. PCAS Description and Business Overview Table 94. PCAS Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 95. PCAS Product Table 96. PCAS Recent Development Table 97. Patheon N.V. Corporation Information Table 98. Patheon N.V. Description and Business Overview Table 99. Patheon N.V. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 100. Patheon N.V. Product Table 101. Patheon N.V. Recent Development Table 102. AstraZeneca Corporation Information Table 103. AstraZeneca Description and Business Overview Table 104. AstraZeneca Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 105. AstraZeneca Product Table 106. AstraZeneca Recent Development Table 107. Johnson & Johnson Corporation Information Table 108. Johnson & Johnson Description and Business Overview Table 109. Johnson & Johnson Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 110. Johnson & Johnson Product Table 111. Johnson & Johnson Recent Development Table 112. Merck & Co Corporation Information Table 113. Merck & Co Description and Business Overview Table 114. Merck & Co Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 115. Merck & Co Product Table 116. Merck & Co Recent Development Table 117. BASF SE Corporation Information Table 118. BASF SE Description and Business Overview Table 119. BASF SE Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 120. BASF SE Product Table 121. BASF SE Recent Development Table 122. Catalent Inc. Corporation Information Table 123. Catalent Inc. Description and Business Overview Table 124. Catalent Inc. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 125. Catalent Inc. Product Table 126. Catalent Inc. Recent Development Table 127. Teva Pharmaceuticals Corporation Information Table 128. Teva Pharmaceuticals Description and Business Overview Table 129. Teva Pharmaceuticals Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 130. Teva Pharmaceuticals Product Table 131. Teva Pharmaceuticals Recent Development Table 132. Roche Corporation Information Table 133. Roche Description and Business Overview Table 134. Roche Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 135. Roche Product Table 136. Roche Recent Development Table 137. Cambrex Corporation Corporation Information Table 138. Cambrex Corporation Description and Business Overview Table 139. Cambrex Corporation Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 140. Cambrex Corporation Product Table 141. Cambrex Corporation Recent Development Table 142. GILEAD Science Inc. Corporation Information Table 143. GILEAD Science Inc. Description and Business Overview Table 144. GILEAD Science Inc. Small Molecule Active Pharmaceutical Ingredient Sales (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2017-2022) Table 145. GILEAD Science Inc. Product Table 146. GILEAD Science Inc. Recent Development Table 147. Key Raw Materials Lists Table 148. Raw Materials Key Suppliers Lists Table 149. Small Molecule Active Pharmaceutical Ingredient Customers List Table 150. Small Molecule Active Pharmaceutical Ingredient Distributors List Table 151. Research Programs/Design for This Report Table 152. Key Data Information from Secondary Sources Table 153. Key Data Information from Primary Sources List of Figures Figure 1. Small Molecule Active Pharmaceutical Ingredient Product Picture Figure 2. Global Small Molecule Active Pharmaceutical Ingredient Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 3. Global Small Molecule Active Pharmaceutical Ingredient Market Size 2017-2028 (US$ Million) Figure 4. Global Small Molecule Active Pharmaceutical Ingredient Sales 2017-2028 (MT) Figure 5. United States Small Molecule Active Pharmaceutical Ingredient Revenue, (US$ Million), 2017 VS 2022 VS 2028 Figure 6. United States Small Molecule Active Pharmaceutical Ingredient Market Size 2017-2028 (US$ Million) Figure 7. United States Small Molecule Active Pharmaceutical Ingredient Sales 2017-2028 (MT) Figure 8. United States Small Molecule Active Pharmaceutical Ingredient Market Share in Global, in Value (US$ Million) 2017-2028 Figure 9. United States Small Molecule Active Pharmaceutical Ingredient Market Share in Global, in Volume (MT) 2017-2028 Figure 10. Small Molecule Active Pharmaceutical Ingredient Report Years Considered Figure 11. Product Picture of Standard API Figure 12. Product Picture of High Potency API Figure 13. Global Small Molecule Active Pharmaceutical Ingredient Market Share by Type in 2022 & 2028 Figure 14. Global Small Molecule Active Pharmaceutical Ingredient Sales in Value by Type (2017-2028) & (US$ Million) Figure 15. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share in Value by Type (2017-2028) Figure 16. Global Small Molecule Active Pharmaceutical Ingredient Sales by Type (2017-2028) & (MT) Figure 17. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share in Volume by Type (2017-2028) Figure 18. Global Small Molecule Active Pharmaceutical Ingredient Price by Type (2017-2028) & (USD/MT) Figure 19. United States Small Molecule Active Pharmaceutical Ingredient Market Share by Type in 2022 & 2028 Figure 20. United States Small Molecule Active Pharmaceutical Ingredient Sales in Value by Type (2017-2028) & (US$ Million) Figure 21. United States Small Molecule Active Pharmaceutical Ingredient Sales Market Share in Value by Type (2017-2028) Figure 22. United States Small Molecule Active Pharmaceutical Ingredient Sales by Type (2017-2028) & (MT) Figure 23. United States Small Molecule Active Pharmaceutical Ingredient Sales Market Share in Volume by Type (2017-2028) Figure 24. United States Small Molecule Active Pharmaceutical Ingredient Price by Type (2017-2028) & (USD/MT) Figure 25. Product Picture of Cardiovascular Diseases Figure 26. Product Picture of Respiratory Disorders Figure 27. Product Picture of Infectious Diseases Figure 28. Product Picture of Others Figure 29. Global Small Molecule Active Pharmaceutical Ingredient Market Share by Application in 2022 & 2028 Figure 30. Global Small Molecule Active Pharmaceutical Ingredient Sales in Value by Application (2017-2028) & (US$ Million) Figure 31. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share in Value by Application (2017-2028) Figure 32. Global Small Molecule Active Pharmaceutical Ingredient Sales by Application (2017-2028) & (MT) Figure 33. Global Small Molecule Active Pharmaceutical Ingredient Sales Market Share in Volume by Application (2017-2028) Figure 34. Global Small Molecule Active Pharmaceutical Ingredient Price by Application (2017-2028) & (USD/MT) Figure 35. United States Small Molecule Active Pharmaceutical Ingredient Market Share by Application in 2022 & 2028 Figure 36. United States Small Molecule Active Pharmaceutical Ingredient Sales in Value by Application (2017-2028) & (US$ Million) Figure 37. United States Small Molecule Active Pharmaceutical Ingredient Sales Market Share in Value by Application (2017-2028) Figure 38. United States Small Molecule Active Pharmaceutical Ingredient Sales by Application (2017-2028) & (MT) Figure 39. United States Small Molecule Active Pharmaceutical Ingredient Sales Market Share in Volume by Application (2017-2028) Figure 40. United States Small Molecule Active Pharmaceutical Ingredient Price by Application (2017-2028) & (USD/MT) Figure 41. North America Small Molecule Active Pharmaceutical Ingredient Sales in Volume Growth Rate 2017-2028 (MT) Figure 42. North America Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 43. U.S. Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 44. Canada Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 45. Europe Small Molecule Active Pharmaceutical Ingredient Sales in Volume Growth Rate 2017-2028 (MT) Figure 46. Europe Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 47. Germany Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 48. France Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 49. U.K. Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 50. Italy Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 51. Russia Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 52. Asia-Pacific Small Molecule Active Pharmaceutical Ingredient Sales in Volume Growth Rate 2017-2028 (MT) Figure 53. Asia-Pacific Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 54. China Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 55. Japan Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 56. South Korea Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 57. India Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 58. Australia Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 59. Taiwan Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 60. Indonesia Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 61. Thailand Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 62. Malaysia Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 63. Philippines Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 64. Latin America Small Molecule Active Pharmaceutical Ingredient Sales in Volume Growth Rate 2017-2028 (MT) Figure 65. Latin America Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 66. Mexico Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 67. Brazil Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 68. Argentina Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 69. Middle East & Africa Small Molecule Active Pharmaceutical Ingredient Sales in Volume Growth Rate 2017-2028 (MT) Figure 70. Middle East & Africa Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate 2017-2028 (US$ Million) Figure 71. Turkey Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 72. Saudi Arabia Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 73. U.A.E Small Molecule Active Pharmaceutical Ingredient Sales in Value Growth Rate (2017-2028) & (US$ Million) Figure 74. Small Molecule Active Pharmaceutical Ingredient Value Chain Figure 75. Small Molecule Active Pharmaceutical Ingredient Production Process Figure 76. Channels of Distribution Figure 77. Distributors Profiles Figure 78. Bottom-up and Top-down Approaches for This Report Figure 79. Data Triangulation Figure 80. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us